Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
India · Delayed Price · Currency is INR 108.18
-0.39 (-0.36%)
Jun 1, 2026, 3:29 PM IST
NSE:LOTUSEYE Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 516.17 | 495.63 | 482.1 | 470.44 | 389.1 | 323.59 |
| 516.17 | 495.63 | 482.1 | 470.44 | 389.1 | 323.59 | |
Revenue Growth (YoY) | 5.49% | 2.81% | 2.48% | 20.91% | 20.24% | -20.21% |
Cost of Revenue | 410.16 | 389.33 | 346.44 | 326.07 | 273.31 | 237.89 |
Gross Profit | 106.01 | 106.3 | 135.66 | 144.37 | 115.79 | 85.7 |
Selling, General & Admin | 33.14 | 33.14 | 34.58 | 34 | 31.53 | 23.41 |
Other Operating Expenses | 41.09 | 34.43 | 31.39 | 30.25 | 22.81 | 24.69 |
Operating Expenses | 94.87 | 97.64 | 103.24 | 94.05 | 79.36 | 71.4 |
Operating Income | 11.14 | 8.66 | 32.42 | 50.32 | 36.43 | 14.3 |
Interest Expense | -6.22 | -3.55 | -0.97 | -0.98 | -1.28 | -0.56 |
Interest & Investment Income | 3.58 | 3.58 | 4.98 | 4.67 | 4.32 | 3.91 |
Other Non Operating Income (Expenses) | 4.06 | 5.04 | 3.66 | 2.52 | 1.56 | 1.47 |
EBT Excluding Unusual Items | 12.56 | 13.73 | 40.08 | 56.54 | 41.04 | 19.11 |
Other Unusual Items | 0.14 | 0.1 | 0.06 | -0.02 | -0.1 | 0.81 |
Pretax Income | 12.7 | 13.83 | 40.14 | 56.52 | 40.94 | 19.92 |
Income Tax Expense | 6.18 | 6.43 | 10.99 | 15.75 | 11.09 | 4.24 |
Net Income | 6.52 | 7.39 | 29.15 | 40.78 | 29.85 | 15.68 |
Net Income to Common | 6.52 | 7.39 | 29.15 | 40.78 | 29.85 | 15.68 |
Net Income Growth | 27.60% | -74.63% | -28.52% | 36.62% | 90.34% | 47.28% |
Shares Outstanding (Basic) | 20 | 21 | 21 | 21 | 21 | 21 |
Shares Outstanding (Diluted) | 20 | 21 | 21 | 21 | 21 | 21 |
Shares Change (YoY) | -3.11% | -1.35% | 0.07% | 0.38% | -0.34% | - |
EPS (Basic) | 0.32 | 0.36 | 1.40 | 1.96 | 1.44 | 0.75 |
EPS (Diluted) | 0.32 | 0.36 | 1.40 | 1.96 | 1.44 | 0.75 |
EPS Growth | 31.70% | -74.29% | -28.57% | 36.11% | 90.98% | 47.28% |
Free Cash Flow | - | -21.28 | 0.4 | 12.9 | -2.73 | 22.55 |
Free Cash Flow Per Share | - | -1.04 | 0.02 | 0.62 | -0.13 | 1.08 |
Dividend Per Share | - | - | - | 0.500 | 0.500 | 0.500 |
Gross Margin | 20.54% | 21.45% | 28.14% | 30.69% | 29.76% | 26.48% |
Operating Margin | 2.16% | 1.75% | 6.73% | 10.70% | 9.36% | 4.42% |
Profit Margin | 1.26% | 1.49% | 6.04% | 8.67% | 7.67% | 4.85% |
Free Cash Flow Margin | - | -4.29% | 0.08% | 2.74% | -0.70% | 6.97% |
EBITDA | 21.79 | 28.01 | 63.37 | 74.74 | 55.73 | 33.98 |
EBITDA Margin | 4.22% | 5.65% | 13.14% | 15.89% | 14.32% | 10.50% |
D&A For EBITDA | 10.65 | 19.35 | 30.95 | 24.42 | 19.3 | 19.68 |
EBIT | 11.14 | 8.66 | 32.42 | 50.32 | 36.43 | 14.3 |
EBIT Margin | 2.16% | 1.75% | 6.73% | 10.70% | 9.36% | 4.42% |
Effective Tax Rate | 48.63% | 46.53% | 27.39% | 27.86% | 27.09% | 21.30% |
Revenue as Reported | 528.21 | 508.64 | 495.13 | 481.89 | 397.96 | 331.12 |